HIV preferentially infects HIV-specific CD4+ T cells

Nature

Volumn 417, Issue 6884, 2002, Pages 95-98

  Douek, Daniel C ^a,c   Brenchley, Jason M ^a   Betts, Michael R ^a   Ambrozak, David R ^a   Hill, Brenna J ^a   Okamoto, Yukari ^a   Casazza, Joseph P ^d   Kuruppu, Janaki ^a   Kunstman, Kevin ^e   Wolinsky, Steven ^e   Grossman, Zvi ^b,f   Dybul, Mark ^b   Oxenius, Annette ^g   Price, David A ^g   Connors, Mark ^b   Koup, Richard A ^a  

^a Vaccine Research Center   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f TEL AVIV UNIVERSITY   (Israel)

^g JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; DNA; IMMUNOLOGY; PATIENT TREATMENT;

STRUCTURED THERAPY INTERRUPTION;

CELLS;

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; VIRUS DNA;

HUMAN IMMUNODEFICIENCY VIRUS;

ARTICLE; CASE REPORT; CELL SPECIFICITY; CELLULAR IMMUNITY; DISEASE SEVERITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS REPLICATION;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELLS, CULTURED; DNA, VIRAL; HIV; HIV INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; MALE; ORGAN SPECIFICITY; POLYMERASE CHAIN REACTION; VIRAL LOAD;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0037007670     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/417095a     Document Type: Article

References (32)

1. HIV infection: Where have all the T cells gone?
2. + T-cell depletion in HIV disease
3. + T cell responses associated with control of viremia
4. Immune control of HIV-1 after early treatment of acute infection
5. + T lymphocytes
6. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
7. Analysis of total human immunodeficiency virus (HIV)-specific CD4 and CD8 T-cell responses: Relationship to viral load in untreated HIV infection
8. HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues
9. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
10. Helper T cell differentiation is controlled by the cell cycle
11. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection
12. - T cell proliferative ability but not toss of human immunodeficiency virus type 1 specificity equates with progression to disease
13. + T cell proliferation
14. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
15. Quantitative image analysis of HIV-1 infection in lymphoid tissue
16. + T cell repopulation of lymphoid tissues after treatment of HIV-1 infection
17. - T cell demographics and dynamics in lymphatic tissues
18. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances transinfection of T cells
19. Antigenic stimulation by BCG vaccine as an in vivo driving force for SIV replication and dissemination
20. Multiple modes of cellular activation and virus transmission in HIV infection: A role for chronically and latently infected cells in sustaining viral replication
21. + T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI
22. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
23. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
24. Transient mobilization of human immunodefidency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection
25. The infiltration kinetics of simian immunodeficiency virus-specific T cells drawn to sites of high antigenic stimulation determines local in vivo viral escape
26. Control of HIV despite the discontinuation of antiretroviral therapy
27. HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy
28. Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia
29. Less is more? ST1 in acute and chronic HIV-1 infection
30. Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters
31. + T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency
32. Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I